0 CHECKOUT

Biomarkers Market by Product (Consumables, Services), Type (Predictive, Pharmacodynamic, Safety), Application (Diagnostics, Drug Discovery, Personalized Medicine) & by Disease Indication (Cardiovascular, Immunological) - Global Forecast to 2020

  • ID: 3332359
  • July 2015
  • Region: Global
  • 182 Pages
  • Markets and Markets
Global Biomarkers Market Expected to Reach $45.55 Billion by 2020 from $24.10 Billion in 2015 at a CAGR of 13.58%

FEATURED COMPANIES

  • Biosims Technologies
  • Cisbio Bioassays
  • ENZO Biochem, Inc.
  • Merck & Co, Inc.
  • Perkinelmer, Inc.
  • Qiagen N.V.
  • MORE

The global biomarkers market is expected to reach $45.55 Billion by 2020 from $24.10 Billion in 2015, at a CAGR of 13.58% between 2015 and 2020. Increasing healthcare expenditure & R&D spending and the increasing utility of biomarkers for diagnostics are expected to drive the market. Market growth will also be aided by the low cost of clinical trials in developing countries and new initiatives undertaken for biomarker research. On the other hand, the need for high capital investment, low benefit-cost ratio, poorly suited regulatory & reimbursement systems, and the high cost of tests and sample collection & storage are the major factors restraining the growth of this market.

This report segments the global market by product, type of biomarker, application, disease indication, and geography. The product segments included in this report are consumables, services, & software. Based on type, biomarkers are segmented into safety, efficacy, and validation biomarkers. The applications included in this report are diagnostics development, drug discovery & development, personalized medicine, disease risk assessment and other applications. The disease indication segments READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biosims Technologies
  • Cisbio Bioassays
  • ENZO Biochem, Inc.
  • Merck & Co, Inc.
  • Perkinelmer, Inc.
  • Qiagen N.V.
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered in the Report
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Lucrative Opportunities in the Global Biomarkers Market
4.2 Life Cycle Analysis, By Region

5 Market Overview
5.1 Introduction
5.2 Market Segmentation
5.2.1 By Product
5.2.2 By Type
5.2.3 By Application
5.2.4 By Disease Indication
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing Healthcare Expenditure
5.3.1.2 Increase in R&D Funding
5.3.1.3 Increasing Utility of Biomarkers for Diagnostic Purposes
5.3.1.4 Increase in Number of Cros and Low Cost for Conducting Clinical Trials in Developing Countries
5.3.1.5 New Initiatives for Biomarker Research
5.3.2 Restraints
5.3.2.1 High Capital Investment & Low Benefit-Cost Ratio
5.3.2.2 Poorly Suited Regulatory and Reimbursement Systems
5.3.2.3 High Cost of Tests
5.3.2.4 Technical Issues Related to Sample Collection and Storage
5.3.3 Opportunities
5.3.3.1 Personalized Medicine
5.3.3.2 Companion Diagnostics
5.3.3.3 Emerging Economies
5.3.3.4 High Prevalence of Cancer
5.3.4 Challenges
5.3.4.1 Proving Clinical Validity and Utility of Biomarkers-Based Tests

6 Biomarkers Market, By Products
6.1 Introduction
6.2 Consumables
6.3 Services
6.4 Software

7 Biomarkers Market, By Type
7.1 Introduction
7.2 Safety Biomarkers
7.3 Efficacy Biomarkers
7.3.1 Predictive Biomarkers
7.3.2 Surrogate Biomarkers
7.3.3 Pharmacodynamic Biomarkers
7.3.4 Prognostic Biomarkers
7.4 Validation Biomarkers

8 Biomarkers Market, By Application
8.1 Introduction
8.2 Diagnostics Development
8.3 Drug Discovery and Development
8.4 Personalized Medicine
8.5 Disease Risk Assessment
8.6 Other Applications

9 Biomarkers Market, By Disease Indication
9.1 Introduction
9.2 Cancer
9.3 Cardiovascular Disorders
9.4 Neurological Disorders
9.5 Immunological Disorders
9.6 Other Diseases

10 Biomarkers Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.4 Asia
10.5 Rest of the World (RoW)

11 Competitive Landscape
11.1 Introduction
11.2 Market Share Analysis, Biomarkers Market
11.3 Competitive Situation and Trends
11.3.1 Acquisitions
11.3.2 Agreements, Collaborations, Expansion, Joint Ventures, and Partnerships
11.3.3 New Product and Service Launches
11.3.4 Other Developments

12 Company Profiles
12.1 Introduction
12.2 Bio-Rad Laboratories, Inc.
12.2.1 Business Overview
12.2.2 Product Offerings
12.2.3 Recent Developments
12.2.4 MnM View
12.3 EKF Diagnostics Holdings, Inc.
12.3.1 Business Overview
12.3.2 Product Offerings
12.3.3 Recent Developments
12.3.4 MnM View
12.4 ENZO Biochem, Inc.
12.4.1 Business Overview
12.4.2 Product Offerings
12.4.3 Recent Developments
12.4.4 MnM View
12.5 Merck & Co, Inc.
12.5.1 Business Overview
12.5.2 Product & Services
12.5.3 Recent Developments
12.5.4 MnM View
12.6 Perkinelmer, Inc.
12.6.1 Business Overview
12.6.2 Products and Services
12.6.3 Recent Developments
12.6.4 MnM View
12.7 Qiagen N.V.
12.7.1 Business Overview
12.7.2 Product Offerings
12.7.3 Recent Developments
12.7.4 MnM View
12.8 Biosims Technologies
12.8.1 Business Overview
12.8.2 Product Offerings
12.8.3 Recent Developments
12.9 Cisbio Bioassays
12.9.1 Business Overview
12.9.2 Products and Services
12.9.3 Recent Developments
12.10 Meso Scale Diagnostics, LLC.
12.10.1 Business Overview
12.10.2 Products and Services
12.10.3 Recent Developments
12.11 Signosis, Inc.
12.11.1 Business Overview
12.11.2 Product Offerings
12.11.3 Recent Developments
12.12 Singulex, Inc.
12.12.1 Business Overview
12.12.2 Products and Services
12.12.3 Recent Developments

13 Appendix
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Introducing RT: Real Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports

List of Tables

Table 1 Biomarkers Market Snapshot
Table 2 Increasing Healthcare Expenditure is Propelling the Growth of Biomarkers Market
Table 3 Poorly Suited Regulatory and Reimbursement Systems—An Entry Barrier for New Entrants
Table 4 List of Fda-Approved Biomarkers for Different Types of Cancer
Table 5 Emerging Economies Present Significant Growth Opportunities
Table 6 Proving the Clinical Validity & Utility of Biomarkers-Based Tests is A Major Challenge for Market Players
Table 7 Biomarkers Market Size, By Product, 2013 - 2020 ($Billion)
Table 8 Biomarker Consumables Market, By Region, 2013 - 2020 ($Billion)
Table 9 North America: Biomarker Consumables Market, By Region, 2013 - 2020 ($Billion)
Table 10 Biomarker Services Market, By Region, 2013 - 2020 ($Billion)
Table 11 North America: Biomarker Services Market, By Region, 2013 - 2020 ($Billion)
Table 12 Biomarker Software Market, By Region, 2013 - 2020 ($Billion)
Table 13 North America: Biomarker Software Market, By Region, 2013 - 2020 ($Million)
Table 14 Biomarkers Market Size, By Type, 2013 - 2020 ($Billion)
Table 15 Safety Biomarkers Market Size, By Region, 2013 - 2020 ($Billion)
Table 16 North America: Safety Biomarkers Market, By Country, 2013 - 2020 ($Billion)
Table 17 Efficacy Biomarkers Market Size, By Type, 2013 - 2020 ($Billion)
Table 18 Efficacy Biomarkers Market Size, By Region, 2013 - 2020 ($Billion)
Table 19 North America: Efficacy Biomarkers Market Size, By Country, 2013 - 2020 ($Billion)
Table 20 Predictive Biomarkers Market Size, By Region, 2013 - 2020 ($Billion)
Table 21 North America: Predictive Biomarkers Market Size, By Country, 2013 - 2020 ($Million)
Table 22 Surrogate Biomarkers Market Size, By Region, 2013 - 2020 ($Billion)
Table 23 North America: Surrogate Biomarkers Market Size, By Country, 2013 - 2020 ($Billion)
Table 24 Pharmacodynamic Biomarkers Market Size, By Region, 2013 - 2020 ($Billion)
Table 25 North America: Pharmacodynamic Biomarkers Market Size, By Country, 2013 - 2020 ($Billion)
Table 26 Prognostic Biomarkers Market Size, By Region, 2013 - 2020 ($Billion)
Table 27 North America: Prognostic Biomarkers Market Size, By Country, 2013 - 2020 ($Billion)
Table 28 Validation Biomarkers Market Size, By Region, 2013 - 2020 ($Billion)
Table 29 North America: Validation Biomarkers Market Size, By Country, 2013 - 2020 ($Billion)
Table 30 Biomarkers Market Size, By Application, 2013 - 2020 ($Billion)
Table 31 Diagnostics Development Market Size, By Region, 2013 - 2020 ($Billion)
Table 32 North America: Diagnostics Development Market Size, By Country, 2013 - 2020 ($Billion)
Table 33 Drug Discovery and Development Market Size, By Region, 2013 - 2020 ($Billion)
Table 34 North America: Drug Discovery and Development Market Size, By Country, 2013 - 2020 ($Billion)
Table 35 Personalized Medicine Market Size, By Region, 2013 - 2020 ($Billion)
Table 36 North America: Personalized Medicine Market Size, By Country, 2013 - 2020 ($Billion)
Table 37 Disease Risk Assessment Market Size, By Region, 2013 - 2020 ($Billion)
Table 38 North America: Disease Risk Assessment Market Size, By Country, 2013 - 2020 ($Billion)
Table 39 Biomarkers Market Size for Other Applications, By Region, 2013 - 2020 ($Billion)
Table 40 North America: Market Size for Other Applications, By Country, 2013 - 2020 ($Billion)
Table 41 Biomarkers Market Size, By Disease Indication, 2013 - 2020 ($Billion)
Table 42 Key Cancer Biomarkers in Clinical Use
Table 43 Asia to Be the Fastest-Growing Regional Segment for the Cancer Disease Indication Segment
Table 44 Biomarkers Market Size for Cancer, By Region, 2013 - 2020 ($Billion)
Table 45 North America: Market Size for Cancer, By Region, 2013 - 2020 ($Billion)
Table 46 Cardiovascular Disorder Biomarkers
Table 47 Biomarkers Market Size for Cardiovascular Disorders, By Region, 2013 - 2020 ($Billion)
Table 48 North America: Biomarkers Market Size for Cardiovascular Disorders, By Region, 2013 - 2020 ($Billion)
Table 49 Biomarkers Market Size for Neurological Disorders, By Region, 2013 - 2020 ($Billion)
Table 50 North America: Biomarkers Market Size for Neurological Disorders, By Region, 2013 - 2020 ($Billion)
Table 51 Biomarkers for Immunological Diseases
Table 52 Biomarkers Market Size for Immunological Disorders, By Region, 2013 - 2020 ($Billion)
Table 53 North America: Biomarkers Market Size for Immunological Disorders, By Region, 2013 - 2020 ($Billion)
Table 54 Biomarkers for Renal Disorders
Table 55 Biomarkers Market Size for Other Disease Indications, By Region, 2013 - 2020 ($Billion)
Table 56 North America: Market Size for Other Disease Indications, By Region, 2013 - 2020 ($Billion)
Table 57 Biomarkers Market Size, By Region, 2013 - 2020 ($Million)
Table 58 North America: Market Size, By Country, 2013 - 2020 ($Billion)
Table 59 North America: Market Size, By Product, 2013 - 2020 ($Billion)
Table 60 North America: Market Size, By Type, 2013 - 2020 ($Billion)
Table 61 North America: Efficacy Biomarkers Market Size, By Type, 2013 - 2020 ($Billion)
Table 62 North America: Market Size, By Application, 2013 - 2020 ($Billion)
Table 63 North America: Market Size, By Disease Indication, 2013 - 2020 ($Billion)
Table 64 U.S.: Market Size, By Product, 2013 - 2020 ($Billion)
Table 65 U.S.: Market Size, By Type, 2013 - 2020 ($Billion)
Table 66 U.S.: Efficacy Biomarkers Market Size, By Type, 2013 - 2020 ($Billion)
Table 67 U.S.: Market Size, By Application, 2013 - 2020 ($Billion)
Table 68 U.S.: Market Size, By Disease Indication, 2013 - 2020 ($Billion)
Table 69 Canada: Market Size, By Product, 2013 - 2020 ($Billion)
Table 70 Canada: Market Size, By Type, 2013 - 2020 ($Billion)
Table 71 Canada: Efficacy Biomarkers Market Size, By Type, 2013 - 2020 ($Billion)
Table 72 Canada: Market Size, By Application, 2013 - 2020 ($Billion)
Table 73 Canada: Market Size, By Disease Indication, 2013 - 2020 ($Billion)
Table 74 Europe: Market Size, By Product, 2013 - 2020 ($Billion)
Table 75 Europe: Market Size, By Type, 2013 - 2020 ($Billion)
Table 76 Europe: Efficacy Biomarkers Market Size, By Type, 2013 - 2020 ($Billion)
Table 77 Europe: Market Size, By Application, 2013 - 2020 ($Billion)
Table 78 Europe: Market Size, By Disease Indication, 2013 - 2020 ($Billion)
Table 79 Asia: Market Size, By Product, 2013 - 2020 ($Billion)
Table 80 Asia: Market Size, By Type, 2013 - 2020 ($Billion)
Table 81 Asia: Efficacy Biomarkers Market Size, By Type, 2013 - 2020 ($Billion)
Table 82 Asia: Market Size, By Application, 2013 - 2020 ($Billion)
Table 83 Asia: Market Size, By Disease Indication, 2013 - 2020 ($Billion)
Table 84 RoW: Market Size, By Product, 2013 - 2020 ($Billion)
Table 85 RoW: Market Size, By Type, 2013 - 2020 ($Billion)
Table 86 RoW: Efficacy Biomarkers Market Size, By Type, 2013 - 2020 ($Billion)
Table 87 RoW: Market Size, By Application, 2013 - 2020 ($Billion)
Table 88 RoW: Market Size, By Disease Indication, 2013 - 2020 ($Billion)
Table 89 Market Developments Between January 2012 and May 2015
Table 90 Acquisition, 2012 - 2015
Table 91 Agreement, Collaborations, Expansion, Joint Ventures and Partnerships, 2012 - 2015
Table 92 New Product and Service Launches, 2012 - 2015
Table 93 Other Developments, 2012 - 2015

List of Figures

Figure 1 Biomarkers Market
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Biomarkers Market Size, By Product, 2015 vs 2020 ($Billion)
Figure 8 Market Size, By Type, 2015 vs 2020 ($Billion)
Figure 9 Market Size, By Application, 2015 vs 2020 ($Billion)
Figure 10 Market Size, By Disease Indication, 2015 vs 2020 ($Billion)
Figure 11 Market Size, By Region, 2015 vs 2020 ($Billion)
Figure 12 Global Biomarkers Market to Witness High Growth During the Forecast Period
Figure 13 Consumables Segment to Account for the Largest Market Share in 2015
Figure 14 Asia to Witness Highest Growth Rate in the Forecast Period
Figure 15 Asian Market Shows Lucrative Growth Opportunites
Figure 16 Biomarkers Market: By Product
Figure 17 Biomarkers Market: By Type
Figure 18 Biomarkers Market: By Application
Figure 19 Biomarkers Market: By Disease Indication
Figure 20 Biomarkers Market: Drivers, Restraints, Opportunities, and Challenges
Figure 21 Increasing Healthcare Expenditure is the Most Important Driver for the Market
Figure 22 Increasing R&D Investments Boosting Growth in the Market
Figure 23 Biomarkers Market, By Product
Figure 24 Consumables Segment to Command the Largest Share of the Biomarkers Market in 2015
Figure 25 North America Will Be the Largest Regional Segment of the Consumables Market in 2015
Figure 26 Asia to Be the Fastest-Growing Regional Segment of the Biomarker Services Market Between 2015 and 2020
Figure 27 North America to Command the Largest Share of the Biomarker Software Market in 2015
Figure 28 Biomarkers Market, By Type
Figure 29 Safety Biomarkers to Command the Largest Share of the Market in 2015
Figure 30 Asia to Be the Fastest-Growing Regional Segment for Safety Biomarkers in the Forecast Period
Figure 31 Efficacy Biomarkers Market, By Type
Figure 32 Predictive Biomarkers Segment to Command the Largest Share of the Efficacy Biomarkers Market in 2015
Figure 33 North America to Be the Largest Regional Segment for Efficacy Biomarkers in 2015
Figure 34 Asia to Be the Fastest-Growing Regional Segment of the Predictive Biomarkers Market Between 2015 and 2020
Figure 35 North America to Command the Largest Share of the Surrogate Biomarkers Market in 2015
Figure 36 Asia to Be the Fastest-Growing Regional Segment for Pharmacodynamic Biomarkers in the Forecast Period
Figure 37 North America to Be the Largest Regional Segment of the Prognostic Biomarkers Market in 2015
Figure 38 Asia to Be the Fastest-Growing Regional Segment for Validation Biomarkers Between 2015 and 2020
Figure 39 Biomarkers Market, By Application
Figure 40 Diagnostics Development to Command the Largest Share of the Market in 2015
Figure 41 North America is Expected to Be the Largest Regional Market for Diagnostics Development
Figure 42 Asia to Be the Fastest-Growing Regional Segment in the Drug Discovery and Development Market
Figure 43 North America to Command the Largest Share of the Personalized Medicine Market in 2015
Figure 44 Asia is the Fastest-Growing Regional Segment for Disease Risk Assessment
Figure 45 North America to Command the Largest Share of the Market for Other Applications
Figure 46 Biomarkers Market, By Disease Indication
Figure 47 Cancer Will Be the Largest Disease Indication Segment of the Biomarkers Market in 2015
Figure 48 North America to Be the Largest Regional Segment for Biomarkers for Cardiovascular Disorders in 2015
Figure 49 Asian Biomarkers Market for Neurological Disorders to Grow at the Highest Rate
Figure 50 North America to Command the Largest Share of the Biomarkers Market for Immunological Disorders in 2015
Figure 51 Asia to Be the Fastest-Growing Regional Segment of the Biomarkers Market for Other Disease Indications
Figure 52 Global Economic Indicators (2003 - 2012)
Figure 53 Market Size and Growth Rate, By Region, 2015-2020
Figure 54 Market in Asia to Witness Highest Growth Rate From 2015 to 2020
Figure 55 North America: Economic Indicators (2003 - 2012)
Figure 56 North America: Market Snapshot
Figure 57 Consumables is Estimated to Be the Largest Product Segment of the North American Biomarkers Market in 2015
Figure 58 Safety Biomarkers to Command the Largest Share of the North American Biomarkers Market By 2020
Figure 59 Predictive Biomarkers Segment Will Continue to Dominate the Efficacy Biomarkers Market in North America
Figure 60 Diagnostics Development Segment to Account for the Largest Share of the North American Biomarkers Applications Market in 2015
Figure 61 Cancer to Account for the Largest Disease Indication Segment of the North American Biomarkers Market in 2015
Figure 62 U.S.: Economic Indicators (2003 - 2012)
Figure 63 Consumables to Account for the Largest Share of the U.S. Biomarkers Products Market in 2015
Figure 64 Safety Biomarkers to Form the Largest Segment of the U.S. Biomarkers Market in 2015
Figure 65 Predictive Biomarkers Will Continue to Dominate the Efficacy Biomarkers Market in the U.S.
Figure 66 Diagnostics Development to Command the Largest Share of the U.S. Biomarkers Applications Market in 2015
Figure 67 Cancer to Form the Largest Disease Indication Segment of the U.S. Biomarkers Market in 2015
Figure 68 Canada: Economic Indicators (2003-2012)
Figure 69 Consumables to Account for the Largest Segment of the Canadian Biomarkers Products Market in 2015
Figure 70 Safety Biomarkers to Dominate the Canadian Biomarkers Market By 2020
Figure 71 Predictive Biomarkers Will Continue to Dominate the Canadian Efficacy Biomarkers Market
Figure 72 Diagnostics Development Segment to Account for the Largest Share of the Canadian Biomarkers Market in 2015
Figure 73 Cancer to Form the Largest Disease Indication Segment of the Canadian Biomarkers Market in 2015
Figure 74 Europe: Economic Indicators (2003 - 2012)
Figure 75 Consumables is Estimated to Be the Largest Product Segment of the European Biomarkers Market in 2015
Figure 76 Safety Biomarkers to Account for the Largest Share of the European Biomarkers Market in 2015
Figure 77 Predictive Biomarkers to Account for the Largest Share of the European Efficacy Biomarkers Market in 2015
Figure 78 Diagnostics Development Segment to Account for the Largest Share of the European Biomarkers Applications Segment in 2015
Figure 79 Cancer to Form the Largest Disease Indication Segment of the European Biomarkers Market in 2015
Figure 80 Asia: Economic Indicators (2003 - 2012)
Figure 81 Asia: Market Snapshot
Figure 82 Market Snapshot
Figure 83 Consumables is Estimated to Be the Largest Segment of the Asian Biomarkers Market in 2015
Figure 84 Safety Biomarkers to Account for the Largest Share of the Asian Biomarkers Market in 2015
Figure 85 Predictive Biomarkers to Account for the Largest Share of the Asian Efficacy Biomarkers Market in 2015
Figure 86 Diagnostics Development to Account for the Largest Share of the Asian Biomarkers Applications Market in 2015
Figure 87 Cancer to Form the Largest Disease Indication Segment of the Asian Biomarkers Market in 2015
Figure 88 Rest of the World: Economic Indicators (2003 - 2012)
Figure 89 Consumables Segment is Expected to Account for the Largest Share of the RoW Biomarkers Products Market in 2015
Figure 90 Safety Biomarkers to Account for the Largest Share of the RoW Biomarkers Market in 2015
Figure 91 Predictive Biomarkers to Account for the Largest Share of the RoW Efficacy Biomarkers Market in 2015
Figure 92 Diagnostics Development to Account for the Largest Share of the RoW Biomarkers Applications Market in 2015
Figure 93 Cancer to Form the Largest Disease Indication Segment of the RoW Biomarkers Market in 2015
Figure 94 New Product Launch, the Key Strategy Adopted By Players in the Market
Figure 95 Market Share Analysis, By Key Players, 2014
Figure 96 Financial Performance of Leading Market Players
Figure 97 Company Snapshot: Bio-Rad Laboratories, Inc.
Figure 98 Company Snapshot: EKF Diagnostics Holdings, Inc.
Figure 99 Company Snapshot: ENZO Biochem, Inc.
Figure 100 Company Snapshot: Merck & Co, Inc.
Figure 101 Company Snapshot: Perkinelmer, Inc.
Figure 102 Company Snapshot: Qiagen N.V.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biosims Technologies
  • Cisbio Bioassays
  • ENZO Biochem, Inc.
  • Merck & Co, Inc.
  • Perkinelmer, Inc.
  • Qiagen N.V.
  • MORE

The global biomarkers market is valued $24.10 Billion in 2015. The market is expected to reach $45.55 Billion by 2020 at a CAGR of 13.58% from 2015 to 2020. Biomarkers are characteristic biomolecules in the human body. The normal physiological levels of biomarkers change in diseased states or on the administration of medication. They are classified on the basis of their application in different medical processes. With rapid innovations in biomarker testing techniques, researchers are now able to test biomarkers very easily. Rapid developments in the field of biomarkers have considerably enhanced the accuracy and efficiency of biomarker testing.

This report segments the global biomarkers market on the basis of product, type, application, disease indication, and geography. The product segments included in this report are consumables, services, and software. The market, on the basis of type, includes safety biomarkers, efficacy biomarkers, and validation biomarkers.

The application segments included in this report are diagnostics development, drug discovery and development, personalized medicine, disease risk assessment, and other applications.

The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). The report maps each test type and product segment in 11 geographic and regional segments.

The major players in this market include QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Enzo Biochem (U.S.), EKF Diagnostics Holdings plc. (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.).

Note: Product cover images may vary from those shown

- Bio-Rad Laboratories, Inc.
- EKF Diagnostics Holdings, Inc.
- ENZO Biochem, Inc.
- Merck & Co, Inc.
- Perkinelmer, Inc.
- Qiagen N.V.
- Biosims Technologies
- Cisbio Bioassays
- Meso Scale Diagnostics, LLC.
- Signosis, Inc.
- Singulex, Inc.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a 1-5 user licence, allowing up to five users have access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Amgen Inc.
  • Bayer AG
  • Bio-Rad Laboratories, Inc.
  • Beckman Coulter, Inc.
  • Novartis AG
  • Baxter International Inc.